AU735381B2 - New use - Google Patents

New use Download PDF

Info

Publication number
AU735381B2
AU735381B2 AU27573/99A AU2757399A AU735381B2 AU 735381 B2 AU735381 B2 AU 735381B2 AU 27573/99 A AU27573/99 A AU 27573/99A AU 2757399 A AU2757399 A AU 2757399A AU 735381 B2 AU735381 B2 AU 735381B2
Authority
AU
Australia
Prior art keywords
dione
indole
group
phenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU27573/99A
Other languages
English (en)
Other versions
AU2757399A (en
Inventor
Janakiraman Ramachandran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9801370A external-priority patent/SE9801370D0/xx
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2757399A publication Critical patent/AU2757399A/en
Application granted granted Critical
Publication of AU735381B2 publication Critical patent/AU735381B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU27573/99A 1998-03-06 1999-03-04 New use Ceased AU735381B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN464/MAS/98 1998-03-06
IN464MA1998 1998-03-06
SE9801370A SE9801370D0 (sv) 1998-04-20 1998-04-20 New use
SE98013270 1998-04-20
PCT/SE1999/000319 WO1999044608A1 (en) 1998-03-06 1999-03-04 New use

Publications (2)

Publication Number Publication Date
AU2757399A AU2757399A (en) 1999-09-20
AU735381B2 true AU735381B2 (en) 2001-07-05

Family

ID=26324794

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27573/99A Ceased AU735381B2 (en) 1998-03-06 1999-03-04 New use

Country Status (13)

Country Link
US (1) US6906090B1 (enExample)
EP (1) EP1058548B1 (enExample)
JP (1) JP2002505286A (enExample)
KR (1) KR20010041625A (enExample)
CN (1) CN100391455C (enExample)
AT (1) ATE249828T1 (enExample)
AU (1) AU735381B2 (enExample)
BR (1) BR9908510A (enExample)
CA (1) CA2320757A1 (enExample)
DE (1) DE69911380T2 (enExample)
NO (1) NO20004419L (enExample)
NZ (1) NZ506217A (enExample)
WO (1) WO1999044608A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6372752B1 (en) * 2000-02-07 2002-04-16 Genzyme Corporation Inha inhibitors and methods of use thereof
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
CN101863823B (zh) * 2010-06-03 2012-02-08 山东大学 吲哚二酮类化合物及其扩环衍生物、制备方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR65270B (en) * 1978-10-10 1980-07-31 Fujisawa Pharmaceutical Co Isatin derivatives and processes for the preparation thereof
IE69677B1 (en) 1989-12-11 1996-10-02 Neurosearch As Isatine derivatives their preparation and use
US5164404A (en) 1991-03-15 1992-11-17 Neurosearch A/S Hydrazone derivatives and their use
SE9103752D0 (sv) 1991-12-18 1991-12-18 Astra Ab New compounds
US5206366A (en) * 1992-08-26 1993-04-27 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds
US5270331A (en) * 1993-01-26 1993-12-14 Pfizer, Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
SE9302080D0 (sv) * 1993-06-16 1993-06-16 Ab Astra New compounds

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ARCH PHARM (WEINHEIM),327(2), 1994'S.MAHBOOBI ET AL P105-114 *
BOLL. SOC. IT. BIOL. SPER., 62(12), 1986, E. PISCOPO.ET AL *
INDIAN J.OF CHEM. VOL21B, AUG 1992 R.S.VERMA ET AL P.775-777 *

Also Published As

Publication number Publication date
HK1030885A1 (en) 2001-05-25
EP1058548A1 (en) 2000-12-13
WO1999044608A1 (en) 1999-09-10
DE69911380T2 (de) 2004-07-01
JP2002505286A (ja) 2002-02-19
CN100391455C (zh) 2008-06-04
WO1999044608A8 (en) 2005-01-06
AU2757399A (en) 1999-09-20
NZ506217A (en) 2002-05-31
NO20004419L (no) 2000-10-20
KR20010041625A (ko) 2001-05-25
ATE249828T1 (de) 2003-10-15
NO20004419D0 (no) 2000-09-05
CA2320757A1 (en) 1999-09-10
DE69911380D1 (de) 2003-10-23
BR9908510A (pt) 2000-11-21
CN1292694A (zh) 2001-04-25
US6906090B1 (en) 2005-06-14
EP1058548B1 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
AU735381B2 (en) New use
US20240325387A1 (en) Combination therapy
RU2560676C2 (ru) Противотуберкулезная композиция, содержащая соединения оксазола
ZA200508523B (en) Treatment of bipolar disorders and associated symptoms
UA81640C2 (ru) Противомикобактериальные соединения, способ их получения, фармацевтическая композиция на их основе
US7491721B2 (en) Antimycobacterial pharmaceutical composition
Peters et al. The experimental chemotherapy of leishmaniasis, V: The activity of potential leishmanicides against ‘L. infantum LV9’in NMRI mice
EP1075261B1 (en) Mycobacterial inhibitors
HK1030885B (en) The use of isatin and oxindole derivatives in the preparation of a medicament for use in the treatment of mycobacterial disease
MXPA00008457A (en) New use
CN101863876A (zh) 有7-(3-氨基-4-肟基)-1-哌啶基取代基的氟喹诺酮及其组合物的应用
JP3016158B2 (ja) 抗ｈｉｖ薬
WO2017070763A1 (pt) Composição farmacêutica, uso da mefloquina em dose fixa, e, método para tratar a tuberculose
KR20160105715A (ko) 페난트레닐계 화합물 또는 이의 유도체, 및 이를 함유하는 결핵 치료용 약학조성물
US7618986B2 (en) Method of treating latent tuberculosis
CN102198133B (zh) 一种8-二氟甲氧基氟喹诺酮及其组合物在治疗结核病中的应用
JPS63287725A (ja) 向知性薬
JPS6143184A (ja) （アラルキルアミノ−２−ｏｒ−プロポキシ）複素環式化合物
HK1177427A (en) Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
JPWO1999036068A1 (ja) カリウムチャネル活性化剤

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)